Target intelligence / Profile preview

Ribosomal protein L7 like 1 pseudogene 2 (RPL7L1P2)

Target: RPL7L1P2
Molecular classification: Other (Pseudogene)

Overview

RPL7L1P2 is a processed pseudogene of the RPL7L1 gene, classified as a pseudogene within the human genome. It does not encode a functional protein and is not known to participate in any biological function, serve as a therapeutic target, or play a role in disease or drug interactions. Like many ribosomal protein gene pseudogenes, RPL7L1P2 is a result of genomic duplication or retrotransposition events and is generally considered non-functional.

Other names: RPL7L1P2ribosomal protein L7-like 1 pseudogene 2

Beyond the preview

Go deeper on Ribosomal protein L7 like 1 pseudogene 2 (RPL7L1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 like 1 pseudogene 2 (RPL7L1P2).

Explore the full profile